CLINICAL TRIALS PROFILE FOR CANCIDAS
✉ Email this page to a colleague
All Clinical Trials for CANCIDAS
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00105144 ↗ | Study of Micafungin in Patients With Invasive Candidiasis or Candidemia | Completed | Astellas Pharma Inc | Phase 3 | 2004-09-01 | The purpose of the study is to determine the safety and effectiveness of two dose levels of micafungin versus caspofungin in the treatment of proven invasive candidiasis or candidemia. |
NCT00388167 ↗ | Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection | Completed | GTEI | 2004-03-01 | We wanted to determine the efficacy and the safety of caspofungin acetate (CANCIDAS®) in the treatment of invader fungal infection (IFI) specifically, Invasive Candidiasis (CI) in adults patients without neutropenia and Invasive Aspergillosis (AI) in adults patients who are refractory to or intolerant of other therapies (i.e., amphotericin B, lipid formulations of amphotericin B, and/or itraconazole). | |
NCT00388167 ↗ | Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection | Completed | SEMICYUC | 2004-03-01 | We wanted to determine the efficacy and the safety of caspofungin acetate (CANCIDAS®) in the treatment of invader fungal infection (IFI) specifically, Invasive Candidiasis (CI) in adults patients without neutropenia and Invasive Aspergillosis (AI) in adults patients who are refractory to or intolerant of other therapies (i.e., amphotericin B, lipid formulations of amphotericin B, and/or itraconazole). | |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CANCIDAS
Condition Name
Clinical Trial Locations for CANCIDAS
Trials by Country
Clinical Trial Progress for CANCIDAS
Clinical Trial Phase
Clinical Trial Sponsors for CANCIDAS
Sponsor Name